Episodios

  • Update on antiobesity medications in adults PART ONE
    Feb 28 2026

    In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Update on antiobesity pharmacotherapy in adults: Current and emerging options,” Dr. Farah Ziyadeh, and Dr. Yael Mauer, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic. The trio discusses available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications currently under investigation.

    Más Menos
    19 m
  • Lipoprotein(a) in clinical practice
    Jan 31 2026

    Listen as Dr. Astefanos Al-Dalakta and Dr. Ashish Sarraju, Cleveland Clinic, join moderator Dr. George Thomas, Cleveland Clinic, to discuss what clinicians need to know about lipoprotein(a) in clinical practice. Topics discussed include summarizes evidence on risk, screening strategies, and evolving therapies for elevated lipoprotein(a).

    Más Menos
    24 m
  • Testing for PFAS ‘forever chemicals’ PART TWO
    Dec 17 2025

    This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”

    Más Menos
    16 m
  • Testing for PFAS ‘forever chemicals’ PART ONE
    Nov 17 2025

    This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”

    Más Menos
    15 m
  • Single-pill combination antihypertensive therapy
    Oct 27 2025

    This podcast moderated by Dr. Craig Nielsen features a discussion with Dr. Maximilian C. Volk, and Dr. Luke J. Laffin, Cleveland Clinic on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Should I consider Cy for my patient with high blood pressure?”

    Más Menos
    25 m
  • Hypercholesterolemia not responding to statins
    Sep 22 2025

    This podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Dr. Faaiq N. Aslam, Mayo Clinic, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “My adult patient’s hypercholesterolemia is not responding to statins—what’s next?”

    Más Menos
    23 m
  • Recreational cannabis legalization
    Aug 21 2025

    This podcast features discussion with Dr. Akhil Anand and Dr. Hannah Snyder, and moderated by Dr. Craig Nielsen, all of Cleveland Clinic. Together, they explore the Cleveland Clinic Journal of Medicine article, “Recreational cannabis legalization: Potential implications for individual and community health.” The conversation delves into the multifaceted issues surrounding recreational cannabis legalization, examining potential health and societal outcomes.

    Más Menos
    26 m
  • Psychedelic assisted therapy PART TWO
    Jul 21 2025

    In this two-part podcast, Dr. Brian S. Barnett, Cleveland Clinic, and Dr. Erin E. Mauney, Massachusetts General Hospital for Children, joins moderator Dr. Adam Brown, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Psychedelic assisted therapy: An overview for the internist.” The trio focuses on what an internist needs to know, from the potential effects, risks, and therapeutic applications of these powerful drugs, with a focus on MDMA-assisted therapy for posttraumatic stress disorder (PTSD) and psilocybin-assisted therapy for depression.

    Más Menos
    27 m